BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8630735)

  • 1. A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL.
    Peace-Brewer AL; Tussey LG; Matsui M; Li G; Quinn DG; Frelinger JA
    Immunity; 1996 May; 4(5):505-14. PubMed ID: 8630735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
    Lewis JW; Neisig A; Neefjes J; Elliott T
    Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for successive peptide binding and quality control stages during MHC class I assembly.
    Lewis JW; Elliott T
    Curr Biol; 1998 Jun; 8(12):717-20. PubMed ID: 9637925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer.
    Pentcheva T; Edidin M
    J Immunol; 2001 Jun; 166(11):6625-32. PubMed ID: 11359816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.
    Luft T; Rizkalla M; Tai TY; Chen Q; MacFarlan RI; Davis ID; Maraskovsky E; Cebon J
    J Immunol; 2001 Sep; 167(5):2529-37. PubMed ID: 11509592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain.
    Suh WK; Derby MA; Cohen-Doyle MF; Schoenhals GJ; Früh K; Berzofsky JA; Williams DB
    J Immunol; 1999 Feb; 162(3):1530-40. PubMed ID: 9973410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vacuolar Pathway of Long Peptide Cross-Presentation Can Be TAP Dependent.
    Ma W; Stroobant V; Heirman C; Sun Z; Thielemans K; Mulder A; van der Bruggen P; Van den Eynde BJ
    J Immunol; 2019 Jan; 202(2):451-459. PubMed ID: 30559321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the mutant HLA-A*0201 heavy chain H74L: impaired TAP-dependent peptide loading.
    Caley RR; Peace-Brewer AL; Matsui M; Frelinger JA
    Hum Immunol; 1999 Sep; 60(9):743-54. PubMed ID: 10527381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
    Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
    J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.
    Lee SP; Thomas WA; Blake NW; Rickinson AB
    Eur J Immunol; 1996 Aug; 26(8):1875-83. PubMed ID: 8765034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential processing of influenza nucleoprotein in human and mouse cells.
    Braud VM; McMichael AJ; Cerundolo V
    Eur J Immunol; 1998 Feb; 28(2):625-35. PubMed ID: 9521073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing.
    Ossevoort MA; Sijts AJ; van Veen KJ; Momburg F; Hämmerling GJ; Seelig A; Butcher GW; Howard JC; Kast WM; Melief CJ
    Eur J Immunol; 1993 Dec; 23(12):3082-8. PubMed ID: 8258321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired transporter associated with antigen processing (TAP) function attributable to a single amino acid alteration in the peptide TAP subunit TAP1.
    Ritz U; Drexler I; Sutter D; Abele R; Huber C; Seliger B
    J Immunol; 2003 Jan; 170(2):941-6. PubMed ID: 12517960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes.
    Zhou X; Liu T; Franksson L; Lederer E; Ljunggren HG; Jondal M
    Scand J Immunol; 1995 Jul; 42(1):66-75. PubMed ID: 7631147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of peptide binding by MHC class I molecules on their interaction with TAP.
    Grandea AG; Androlewicz MJ; Athwal RS; Geraghty DE; Spies T
    Science; 1995 Oct; 270(5233):105-8. PubMed ID: 7569935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity.
    Armandola EA; Momburg F; Nijenhuis M; Bulbuc N; Früh K; Hämmerling GJ
    Eur J Immunol; 1996 Aug; 26(8):1748-55. PubMed ID: 8765016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.